Substituted carbonucleoside derivatives useful as anticancer agents
US10220037B2 · kind B2 · utility
0Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 2017 |
| Grant date | Mar 5, 2019 |
| Priority date | — |
| Expiry date | Jun 2, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C255/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the general formula): processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.